Huntington disease: Nursing

Huntington disease: Nursing

Exam 1

Exam 1

Systemic lupus erythematosus (SLE): Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Klinefelter syndrome
Disorders of sex chromosomes: Pathology review
Cell membrane
Mitosis and meiosis
Metaplasia and dysplasia
Hyperplasia and hypertrophy
Selective permeability of the cell membrane
Endocytosis and exocytosis
Glycolysis
Free radicals and cellular injury
Atrophy, aplasia, and hypoplasia
Necrosis and apoptosis
Body fluid compartments
Prader-Willi syndrome
Potassium homeostasis
Sodium homeostasis
Phosphate, calcium and magnesium homeostasis
Complete metabolic panel (CMP) - Chloride: Nursing
Acid-base map and compensatory mechanisms
Metabolic acidosis
Metabolic alkalosis
Respiratory acidosis
Respiratory alkalosis
Gene regulation
Mendelian genetics and punnett squares
Transcription of DNA
Translation of mRNA
DNA mutations
Nuclear structure
Turner syndrome
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Huntington disease: Nursing
T-cell development
B-cell development
Antibody classes
Introduction to the immune system
Immune response - Adaptive: Nursing
Cell-mediated immunity of natural killer and CD8 cells
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Hypersensitivity reactions - Type II: Nursing
Shock - Anaphylactic: Nursing
Anaphylaxis: Nursing process (ADPIE)
Autoimmunity: Nursing
Immunodeficiency disorders - Secondary: Nursing
Immunodeficiency disorders - Primary: Nursing
HIV (AIDS)
Oncogenes and tumor suppressor genes
Biology of cancer: Nursing
Blood components
Erythropoietin
Coagulation (secondary hemostasis)
Platelet plug formation (primary hemostasis)
Anemia - Iron-deficiency: Nursing
Anemia - Aplastic: Nursing
Pernicious anemia: Year of the Zebra
Anemia of chronic disease: Year of the Zebra
Anemia - Macrocytic: Nursing
Polycythemia vera (NORD)
Polycythemia: Nursing
Thrombocytopenia: Nursing
Essential thrombocythemia (NORD)
Disseminated intravascular coagulation (DIC): Nursing
Thrombosis syndromes (hypercoagulability): Pathology review
Infectious mononucleosis: Nursing
Leukemia: Nursing process (ADPIE)
Lymphoma - Hodgkin and non-Hodgkin: Nursing
Multiple myeloma: Nursing
Hemolytic disease of the fetus and newborn: Nursing
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Sickle cell disease (NORD)
Sickle cell disease: Nursing process (ADPIE)
Thalassemia: Nursing
Hemophilia: Nursing process (ADPIE)
Hemophilia: Year of the Zebra
Immunoglobulins: Nursing pharmacology

Notes

HUNTINGTON DISEASE

KEY POINTS
NOTES
DEFINITION
  • Progressive hereditary neurodegenerative disease

PHYSIOLOGY
  • Basal ganglia
    • Initiate, fine-tune, and complete voluntary movements
    • Receive information from cerebral cortex
    • Respond by sending information to thalamus
      • Direct pathway
      • Indirect pathway
      • Glutamate
      • GABA
      • Dopamine
    • Initiation of voluntary movement

CAUSES AND RISK FACTORS
  • Causes
    • Genetic mutation
  • Risk factors
    • Family history

PATHOPHYSIOLOGY
  • Genetic mutation leads to defective protein aggregates in basal ganglia neurons
  • Early neuronal cell death
    • Especially inhibitory neurons
  • Basal ganglia atrophies
  • Increased dopamine, decreased acetylcholine
  • Aberrant stimulation and inhibition of movement 

SIGNS AND SYMPTOMS
  • Chorea
  • Athetosis
  • Dystonia
  • Dysphagia
  • Dysarthria
  • Piano playing
  • Abnormal eye movements
  • Poor coordination
  • Unsteady gait
  • Depression
  • Anxiety 
  • Paranoia
  • Attention and learning problems
  • Poor impulse control
  • Memory problems
  • Dementia
  • Complications
    • Malnutrition
    • Aspiration
    • Suicide

DIAGNOSIS
  • History
  • Physical assessment
  • Genetic testing
  • CT
  • MRI

TREATMENT
  • Control symptoms and improve quality of life
  • Medications to control motor symptoms
  • Counseling
  • Physical and occupational therapy

MANAGEMENT OF CARE
  • Goals of care
    • Maintain physical safety
    • Ensure nutrition
    • Provide emotional and psychological support
  • Evaluate safety needs
  • Assess ability to ambulation and complete activities of daily living
  • Institute fall precautions
  • Assist with ambulation
  • Collaborate with physical therapist
  • Administer medications as prescribed
  • Assist with activities of daily living
  • Assess nutritional and hydration status
  • Collaborate with speech language pathologist and dietician
  • Offer small, frequent meals that are calorie- and nutrient-dense
  • Assist with feeding as needed
  • Monitor for aspiration
  • Notify HCP
    • Weight decrease
    • No longer able to safely eat
  • Promote rest and sleep
  • Assess coping
  • Allow expression of feelings
  • Reinforce positive coping skills
  • Ensure referral for psychiatric evaluation
    • Notify HCP
      • Signs of depression or suicidal ideation
  • Collaborate with case manager

PATIENT AND FAMILY TEACHING
  • Explain condition, plan of care, and how to safely administer medications
  • Keep follow-up appointments
  • Discuss genetic testing
  • Fall preventions
  • Promote nutrition
  • Notify HCP
    • New or worsening ability to eat
    • Require additional assistance
    • Depression
  • Seek emergency care
    • Suicidal or homicidal thoughts
  • Encourage end-of-life wishes and advanced directives
  • Discuss options with family

Transcript

Watch video only

Huntington disease, or HD for short, is a rare hereditary progressive neurodegenerative condition that’s characterized by motor, psychiatric, and cognitive problems. Okay, first, let’s focus on some anatomy and physiology of the brain; specifically, the basal ganglia, which are a collection of nuclei located deep in the brain. These structures help initiate, fine-tune, and complete voluntary movements. To do this, the basal ganglia receive information from the cerebral cortex, and respond by sending information to the thalamus through two pathways: the direct pathway, which is excitatory; and the indirect pathway, which is inhibitory. And there are two main neurotransmitters involved in these pathways: the excitatory neurotransmitter glutamate, and the inhibitory neurotransmitter GABA. A third neurotransmitter, called dopamine, can play both an excitatory and inhibitory role. By using the excitatory and inhibitory pathways, the basal ganglia controls what signals the thalamus sends to the motor cortex, which results in the initiation of voluntary movement.

Now, Huntington disease is caused by a mutation of the HTT gene, which is located on chromosome 4 and is responsible for the synthesis of the huntingtin protein. This mutation is inherited through the autosomal dominant pattern, meaning that one affected copy of a gene is enough to cause the disease. In other words, a person with Huntington disease has a 50% chance of passing on the affected gene to their child, so the most important risk factors are a family history of Huntington disease. The pathology of Huntington disease results from the mutated HTT gene, which codes for a defective huntingtin protein. This defective protein aggregates in the neurons of the basal ganglia, ultimately causing cell death, especially of GABAergic inhibitory neurons. As the disease progresses over time, more neurons continue to die, and eventually, the basal ganglia undergoes significant atrophy. At the same time, there are also increased levels on dopamine, and decreased levels of acetylcholine, and these neurotransmitter imbalances result in aberrant stimulation and inhibition of movement.

Clinical manifestations of Huntington disease usually occur around 40 years of age, and they include progressive motor, psychiatric, and cognitive manifestations. Motor manifestations include chorea, or involuntary, purposeless, dance-like jerking movements of the limbs and torso; athetosis, or slow, “snake-like” movements that mainly affect the hands; dystonia, which is involuntary muscle contractions that lead to repetitive jerking or twisting movement; dysphagia or trouble swallowing; dysarthria or difficulty speaking; piano playing which involves fidgeting with their hands and wrists with their arms extended; as well as abnormal eye movements, poor coordination, and unsteady gait. On the other hand, psychiatric manifestations include depression, anxiety, and paranoia; while cognitive manifestations include problems with attention, learning, poor impulse control, memory, and even dementia.

Now, there are several important complications of Huntington disease. The first one is malnutrition, since these clients may have a hard time feeding themselves due to involuntary movements and poor coordination. Another important complication is aspiration, which occurs due to discoordinated swallowing, and may result in asphyxiation. Finally, clients with Huntington disease might be at increased risk of suicidal ideation. The diagnosis of Huntington disease is based on the client’s history and physical assessment, followed by genetic testing to confirm the diagnosis. Additionally, brain imaging tests, such as CT scan or MRI, can be used to assess the atrophy of the basal ganglia. Unfortunately, there’s no cure for Huntington disease, so the treatment relies on controlling the symptoms and improving the client’s quality of life. This includes medications to control motor symptoms, such as VMAT2 inhibitors such as tetrabenazine, benzodiazepines like lorazepam, and second generation antipsychotics like risperidone; as well as medications to control psychiatric symptoms, such as selective serotonin reuptake inhibitors or SSRIs for short; Lastly, clients should try to stay active both physically and mentally, and they may benefit from psychiatric counseling and working with physical and occupational therapists.

All right, let’s look at the nursing care you will provide for your client with Huntington’s disease. Your primary nursing goals are to maintain physical safety, ensure adequate nutrition, and provide emotional and psychological support. Start by evaluating your client’s physical safety needs. Assess their ability to ambulate and perform ADLs. Institute fall precautions, and assist them when ambulating by using a gait belt and applying non-skid footwear. Collaborate with the physical therapist for the use of assistive walking devices, such as a cane or walker for added stability, as well as developing a structured rehabilitation program to promote mobility, balance, and coordination. Administer the prescribed VMAT2 inhibitor, and assist them with their ADLs such as oral care, bathing, and grooming, as needed. Next, assess their nutritional and hydration status, including skin turgor, weight, and their ability to take in oral nourishment.

Due to factors like a high caloric demand, difficulty eating related to poor coordination and dysphagia, you’ll need to collaborate with the speech-language therapist to evaluate their swallowing difficulties, as well as with the dietician to develop an individualized plan to support their nutritional needs. Offer small, frequent meals and snacks that are calorie and nutrient dense and easy to swallow, such as avocado, yogurt, mashed potatoes, eggs, and thickened liquids. During mealtimes, ensure they are in a comfortable, upright position; assist them as needed, and monitor them closely for aspiration. Report to the health care provider immediately if there’s a sudden decrease in weight or if they can no longer eat safely. If they aspirate during meals, immediately suction the airway.